Where does Hemosonics LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Hemosonics LLC ranks #14,033 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Hemosonics LLC hold?

Hemosonics LLC holds 21 US utility patents granted between 2015 and 2024, spanning 4 technology areas.

What is Hemosonics LLC's Innovation Score?

Hemosonics LLC has an Innovation Score of 39.3 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Hemosonics LLC focus on?

Hemosonics LLC's top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 17 patents, ranking #897 of 7,863 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Hemosonics LLC's patent grant rate increasing or decreasing?

Hemosonics LLC's recent grant velocity is -38% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Hemosonics LLC's patents?

Hemosonics LLC's patents average 24.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Hemosonics LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Hemosonics LLC

USPTO PatentsView assignee record - 21 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Hemosonics ranks #14,033 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 4 technology areas.

#14,033
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.3/100): 24.9
avg claims per patent: -38%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14033 · US Corporation #14,033 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #14,033/49,997
PHOTO-FINISH Guangzhou Fourto…
CPC-NARROW G01N · 4 areas
INNOV-THIN 39.3/100
CLAIMS-DENSE 24.9 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -38% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Guangzhou Fourto Sanitary Products Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Hemosonics’s 39.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (27%) Velocity 6.7 pts (17%) Breadth 7.1 pts (18%) Claim depth 14.9 pts (38%)

Qualcomm Incorporated · highest

85
Hemosonics · this assignee

39
3D Lighting… · lowest

7

What this shows Hemosonics's Innovation Score is 39.3/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Hemosonics?

Each dot is one of Hemosonics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Hemosonics’s own 24.9 claims/patent is ABOVE the 9.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Hemosonics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Hemosonics's grants concentrate

Hemosonics LLC is a focused PatentsView assignee: 4 CPC subclasses with 81% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2018 (4 grants) versus a trough of 1 in 2015. By volume, Hemosonics sits between Guangzhou Fourto Sanitary Products Co., Ltd. and Huizhou Kimree Technology Co., Ltd..

Hemosonics's three-year grant acceleration

Hemosonics LLC shows 6 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Guangzhou Fourto…

21
HCT Asia

21
Headspin

21
Heartland Tech

21
Heriot-watt Unive…

21
HI Breeding B V

21
Home Control Sing…

21
Huizhou Kimree Te…

21
Hemosonics ◀

21

What this shows Hemosonics holds 21 patents at rank #14,028, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Hemosonics

By rank, the assignees closest to #14,028 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Hemosonics's primary technology class.

Hemosonics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Hemosonics LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	4.8%
2016	2	9.5%
2017	2	9.5%
2018	4	19.0%
2019	4	19.0%
2021	2	9.5%
2022	2	9.5%
2023	2	9.5%
2024	2	9.5%

Which technologies does Hemosonics LLC patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 17

A61B - DIAGNOSIS; SURGERY; Identification 8

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 8

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Hemosonics LLC's patent record in context - here's where to go next.

Hemosonics LLC's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 81% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #14,033 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Hemosonics LLC against Guangzhou Fourto Sanitary Products Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.